Quest Diagnostics IncNYSE:DGX
- LAST PRICE134.9800
- TODAY'S CHANGE (%)0.7200 (0.5363%)
- Bid / Lots134.7800/ 4
- Ask / Lots135.1700/ 4
- Open / Previous Close134.5000 / 134.2600
- Day Range
- 52 Week Range
- Volume11,323
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DGX |
|---|---|---|
| 09:32 ET | 5191 | 134.6 |
| 09:36 ET | 300 | 134.98 |
| 09:38 ET | 1300 | 135.1 |
| 09:39 ET | 174 | 135.1875 |
| 09:41 ET | 674 | 134.7701 |
| 09:43 ET | 100 | 134.98 |
Apr 26, 2024
Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity, from 8:48AM ET on Friday Apr 26, 2024 by Dow Jones
8:48AM ET on Friday Apr 26, 2024 by Dow Jones
Apr 25, 2024
DJ Quest Diagnostics Is Maintained at Equal-Weight by Barclays, from 2:47PM ET on Thursday Apr 25, 2024 by Dow Jones
2:47PM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 24, 2024
DJ Quest Diagnostics Is Maintained at Neutral by Citigroup, from 2:20PM ET on Wednesday Apr 24, 2024 by Dow Jones
2:20PM ET on Wednesday Apr 24, 2024 by Dow JonesDJ Quest Diagnostics Is Maintained at Neutral by UBS, from 12:08PM ET on Wednesday Apr 24, 2024 by Dow Jones
12:08PM ET on Wednesday Apr 24, 2024 by Dow JonesDJ Quest Diagnostics Is Maintained at Hold by Truist Securities, from 9:15AM ET on Wednesday Apr 24, 2024 by Dow Jones
9:15AM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Quest Diagnostics Inc | 14.9B | 18.2x | +7.78% |
Laboratory Corporation of America Holdings | 16.7B | 43.9x | -13.71% |
Healthpeak Properties Inc | 13.3B | 54.4x | -20.31% |
Solventum Corp | 11.1B | 8.2x | --- |
DaVita Inc | 11.7B | 18.2x | +15.72% |
Ventas Inc | 17.8B | -432.7x | --- |
Company Information
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.
Contact Information
- Headquarters
- 500 Plaza DriveSECAUCUS, NJ, United States 07094
- Phone
- 973-520-2700
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- James Davis
- Chief Financial Officer, Executive Vice President
- Sam Samad
- Senior Vice President, General Counsel
- Michael Prevoznik
- Senior Vice President, Chief Commercial Officer
- Mark Delaney
- Senior Vice President - Regional Businesses
- Catherine Doherty
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.9B |
|---|---|
Revenue (TTM) | $9.3B |
Shares Outstanding | 111.1M |
Dividend Yield | 2.22% |
Annual Dividend Rate | 3.0000 USD |
Ex-Dividend Date | 04-05-24 |
Pay Date | 04-22-24 |
Beta | 0.88 |
EPS | $7.43 |
Book Value | $56.82 |
P/E Ratio | 18.2x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | 11.3x |
Operating Margin | 13.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
